Network·Hedge Fund
📍 PARIS
SEC CRD #802-120884
Lauxera Capital Partners — Independent, international, investment fund focused on growth companies in Healthtech Hit enter to search or ESC to close Search Close Search search Menu Scaling impact in Healthtech We are an independent, international, investment fund focused on growth companies in Healthtech. Latest news All Compagnie OrganOx Caresyntax Lifen Antaros Medical Verdot Acandis Biolamina Lumicks Ospi Matrix One Natural Cycles Synovo group Fund Fund I Fund II ESG Impact Lauxera Lauxera Capital Partners Raises €520 million Fund II to Scale a New Generation of European Healthtech Leaders Press release 19 May 2026 Lauxera Capital Partners Raises €520 million Fund II to Scale a New Generation of European Healthtech Leaders Press release Pierre Moustial at Check-up Santé on BFM Business 16 May 2026 Pierre Moustial at Check-up Santé on BFM Business Lauxera Capital Partners supports Matrix One’s strategic expansion with two acquisitions, strengthening its life sciences software platform 7 January 2026 Lauxera Capital Partners supports Matrix One’s strategic expansion with two acquisitions, strengthening its life sciences software platform View all What we do About us We invest in Healthtech businesses at the early profitability stage, helping to catalyze inflections in growth driven by new innovation, commercial investments, business development, and enhanced talent We partner with motivated, world class managers and founders, investing capital and our expertise to improve th
PIERRE MOUSTIAL
PRESIDENT, CO-FOUNDING PARTNER, AND CHIEF COMPLIANCE OFFICER
📞 +33 (0) 1 88 40 58 05
🔒 Sign up for free to view key contact information
Sign up free →This profile has not yet been verified by the firm. Information may be incomplete or outdated. Claim this profile to take control of your listing.
Check Size
$20M–$100M
Location
PARIS
Claim this profile to complete your information, set investment criteria, and start receiving curated deal flow from sponsors on DEALITHIC.